Part E - PRICE NEGOTIATION PROGRAM TO LOWER PRICES FOR CERTAIN HIGH-PRICED SINGLE SOURCE DRUGS
- Section 1320f - Establishment of program
- Section 1320f-1 - Selection of negotiation-eligible drugs as selected drugs
- Section 1320f-2 - Manufacturer agreements
- Section 1320f-3 - Negotiation and renegotiation process
- Section 1320f-4 - Publication of maximum fair prices
- Section 1320f-5 - Administrative duties and compliance monitoring
- Section 1320f-6 - Civil monetary penalties
- Section 1320f-7 - Limitation on administrative and judicial review